Virulence Factors Contributing to Pathogenicity of Candida tropicalis and Its Antifungal Susceptibility Profile
- PMID: 24803934
- PMCID: PMC3996979
- DOI: 10.1155/2014/456878
Virulence Factors Contributing to Pathogenicity of Candida tropicalis and Its Antifungal Susceptibility Profile
Abstract
The incidence of invasive candidiasis has increased over the past few decades. Although Candida albicans remains by far the most common species encountered, in recent years shift towards non-albicans Candida species like Candida tropicalis is noted. Here in this study we determined the virulence factors and antifungal susceptibility profile of 125 C. tropicalis isolated from various clinical specimens. Biofilm formation was seen in 53 (42.4%) isolates. Coagulase production was noted in 18 (14.4%) isolates. Phospholipase enzyme was the major virulent factor produced by C. tropicalis isolates. A total of 39 biofilm forming isolates showed phospholipase activity. Proteinase activity was demonstrated by 65 (52%) isolates. A total of 38 (30.4%) isolates showed haemolytic activity. Maximum isolates demonstrated resistance to fluconazole. Fluconazole resistance was more common in C. tropicalis isolated from blood cultures. Antifungal resistance was more in isolates possessing the ability to produce phospholipase and biofilm. C. tropicalis exhibit a great degree of variation not only in their pathogenicity but also in their antifungal susceptibility profile. The identification of virulence attributes specific for each species and their correlation with each other will aid in the understanding of the pathogenesis of infection.
Figures
Similar articles
-
Virulence Factors and Antifungal Susceptibility Profile of C. tropicalis Isolated from Various Clinical Specimens in Alexandria, Egypt.J Fungi (Basel). 2021 Apr 29;7(5):351. doi: 10.3390/jof7050351. J Fungi (Basel). 2021. PMID: 33947158 Free PMC article.
-
Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of Candida Isolates Causing Invasive Infection in a Tertiary Care Teaching Hospital.Front Cell Infect Microbiol. 2021 Sep 15;11:721439. doi: 10.3389/fcimb.2021.721439. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34604110 Free PMC article.
-
Evaluation of virulence factors and azole resistance mechanisms of Candida tropicalis isolates from head and neck cancer patients with OPC.Iran J Microbiol. 2023 Feb;15(1):163-173. doi: 10.18502/ijm.v15i1.11933. Iran J Microbiol. 2023. PMID: 37069909 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.J Hosp Infect. 2002 Apr;50(4):243-60. doi: 10.1053/jhin.2001.1151. J Hosp Infect. 2002. PMID: 12014897 Review.
Cited by
-
Essential Oil of Cymbopogon nardus (L.) Rendle: A Strategy to Combat Fungal Infections Caused by Candida Species.Int J Mol Sci. 2016 Aug 9;17(8):1252. doi: 10.3390/ijms17081252. Int J Mol Sci. 2016. PMID: 27517903 Free PMC article.
-
Epidemiological Characterization of Clinical Fungal Isolates from Pauls Stradinš Clinical University Hospital, Latvia: A 4-Year Surveillance Report.Life (Basel). 2021 Sep 23;11(10):1002. doi: 10.3390/life11101002. Life (Basel). 2021. PMID: 34685374 Free PMC article.
-
Evaluation of Virulence Factors In vitro, Resistance to Osmotic Stress and Antifungal Susceptibility of Candida tropicalis Isolated from the Coastal Environment of Northeast Brazil.Front Microbiol. 2016 Nov 15;7:1783. doi: 10.3389/fmicb.2016.01783. eCollection 2016. Front Microbiol. 2016. PMID: 27895625 Free PMC article.
-
Evaluation of biofilm formation in the homozygous and heterozygous strains of vaginal Candida albicans isolates.Curr Med Mycol. 2019 Jun;5(2):37-40. doi: 10.18502/cmm.5.2.1160. Curr Med Mycol. 2019. PMID: 31321337 Free PMC article.
-
Antifungal Susceptibility and Biofilm Production of Candida spp. Isolated from Clinical Samples.Int J Microbiol. 2018 Oct 10;2018:7495218. doi: 10.1155/2018/7495218. eCollection 2018. Int J Microbiol. 2018. PMID: 30405717 Free PMC article.
References
-
- Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Giannini MJS. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. Journal of Medical Microbiology. 2013;62(1):10–24. - PubMed
-
- Ortega M, Marco F, Soriano A, et al. Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008. Journal of Hospital Infection. 2011;77(2):157–161. - PubMed
-
- Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infectious Diseases. 2003;3(11):685–702. - PubMed
-
- Deorukhkar S, Saini S. Non albicans Candida species: its isolation pattern, species distribution, virulence factors and antifungal susceptibility profile. International Journal of Medical Science and Public Health. 2013;2(3):533–538.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous